- Home
- MDIA vs CSBR Comparison
MDIA vs CSBR Comparison
Compare MDIA & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- CSBR
- Stock Information
- Founded
- MDIA 2019
- CSBR 1985
- Country
- MDIA United States
- CSBR United States
- Employees
- MDIA 116
- CSBR N/A
- Industry
- MDIA Broadcasting
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDIA Consumer Discretionary
- CSBR Health Care
- Exchange
- MDIA Nasdaq
- CSBR Nasdaq
- Market Cap
- MDIA 92.9M
- CSBR 65.9M
- IPO Year
- MDIA N/A
- CSBR 1986
- Fundamental
- Price
- MDIA $1.94
- CSBR $4.42
- Analyst Decision
- MDIA
- CSBR Strong Buy
- Analyst Count
- MDIA 0
- CSBR 1
- Target Price
- MDIA N/A
- CSBR $6.00
- AVG Volume (30 Days)
- MDIA 118.4K
- CSBR 16.8K
- Earning Date
- MDIA 11-11-2024
- CSBR 12-10-2024
- Dividend Yield
- MDIA N/A
- CSBR N/A
- EPS Growth
- MDIA N/A
- CSBR N/A
- EPS
- MDIA N/A
- CSBR N/A
- Revenue
- MDIA $45,884,000.00
- CSBR $51,655,000.00
- Revenue This Year
- MDIA N/A
- CSBR $9.27
- Revenue Next Year
- MDIA N/A
- CSBR $9.76
- P/E Ratio
- MDIA N/A
- CSBR N/A
- Revenue Growth
- MDIA 22.80
- CSBR N/A
- 52 Week Low
- MDIA $0.40
- CSBR $3.60
- 52 Week High
- MDIA $6.86
- CSBR $7.13
- Technical
- Relative Strength Index (RSI)
- MDIA 57.39
- CSBR 45.62
- Support Level
- MDIA $1.10
- CSBR $4.50
- Resistance Level
- MDIA $2.28
- CSBR $4.74
- Average True Range (ATR)
- MDIA 0.23
- CSBR 0.28
- MACD
- MDIA 0.16
- CSBR -0.03
- Stochastic Oscillator
- MDIA 72.13
- CSBR 20.33
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.